Search company, investor...

Founded Year



Seed VC - II | Alive

Total Raised


Last Raised

$3.15M | 1 yr ago

About Torque3

Torque3 provides a platform that integrates multiple technologies (including virtual reality, robotics, and motion simulation) to deliver a fully immersive patient experience. Its hypothesis is this platform will massively stimulate neuroplasticity in stroke and other neuroimpaired patients, and therefore bring them to much higher levels of recovery & independence than attainable with current treatment modalities. Torque3 was founded in 2016 and is based in Centerville, Utah.

Headquarters Location

1348 W 75 N

San Jose, Utah, 84014,

United States


Torque3's Product Videos

Torque3's Products & Differentiators




Expert Collections containing Torque3

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Torque3 is included in 1 Expert Collection, including AR/VR.



1,437 items

This collection includes companies creating hardware and/or software for augmented reality, virtual reality, and mixed reality applications.

Latest Torque3 News

Torque3 Launches Alpha Program to Evaluate Equipment Designed to Reinvent Stroke Rehabilitation

May 2, 2022

Torque3, the company combining VR and motion simulation technology currently designed for stroke and TBI rehabilitation, announces the opening of the  Alpha Program  – its private pay assessment program developed to evaluate its proprietary experience that puts survivors in direct control of their recovery. Right now, participants have a rare chance to be one of the first few stroke or TBI survivors to experience this revolutionary neurorehabilitation platform. The exclusive opportunity is limited to just 40 participants. Torque3 has created a simulated environment that mimics real-life through tactile feedback from the motion sim base, pedals, and steering arms. Survivors can even feel the G-forces when they make a hard turn, the wind on their face, and smell the forest or waterfall as they pedal past. This fully immersive, multi-modal experience transforms ‘going to therapy’ into a thrilling adventure! The program is anticipated to run for at least six months and is seeking participants who are serious about regaining their independence. Torque3’s engineers will be actively involved with these 40 participants to create an experience tailored to meet their specific requirements, and these survivors will be individually accommodated as much as possible. Torque3 Scheduled to Open Summer 2022 The Alpha Program is scheduled to open in the Summer of 2022, in Centerville, Utah (about 10 miles north of Salt Lake City). This new approach to stroke therapy is designed to be infinitely more tolerable — even enjoyable — than traditional physical therapy, in hopes of making attendance and participation much higher. The goal is to achieve even greater gains and faster results. During this Alpha Program, Torque3 will continue to gather data and fine-tune the survivor experience before moving into the next phase. There are only four of these platforms on the planet, and only three of these can be accessed at any one time. This is an opportunity to be one of the first to explore the benefits of this truly revolutionary rehabilitation platform before it makes its product offering to the rehabilitation market expected in Q4 of 2022. “There is nothing like this for recovery exercise offered anywhere for stroke or TBI survivors, who are often told they’ve ‘plateaued,’ and no further gain is possible. If you don’t accept that, you are perfect for our program. You don’t want to miss out on this incredible opportunity with extremely limited spots available,” said Torque3 CEO David Ellzey. Torque3 offers the only rehabilitation solution that engages the mind, body, and all the senses in an intense, deeply immersive task-orientated therapy. Currently, neurorehabilitation for stroke survivors results is fewer than 10 percent resuming an active, independent lifestyle. This is where Torque3 believes it can make the most significant impact. The ideal candidate for this intensive stroke rehabilitation program is not satisfied with learning to live with their ‘new normal’ of limited mobility and lack of independence after their stroke or TBI. In addition, they often feel overwhelmed and demoralized because of the neurological impact of their stroke/TBI and just want to feel whole again. [Source(s): Torque3, PRWeb]

Torque3 Frequently Asked Questions (FAQ)

  • When was Torque3 founded?

    Torque3 was founded in 2016.

  • Where is Torque3's headquarters?

    Torque3's headquarters is located at 1348 W 75 N, San Jose.

  • What is Torque3's latest funding round?

    Torque3's latest funding round is Seed VC - II.

  • How much did Torque3 raise?

    Torque3 raised a total of $5.54M.

  • Who are the investors of Torque3?

    Investors of Torque3 include Otherwise Fund.

  • Who are Torque3's competitors?

    Competitors of Torque3 include Neuro Rehab VR and 4 more.

  • What products does Torque3 offer?

    Torque3's products include Pre-Revenue.


Compare Torque3 to Competitors

Roam Logo

Roam develops wearable robotic devices integrated for everyday life usage. Its proprietary technology includes pneumatic exoskeleton body support systems with integrated artificial intelligence (AI). The company was founded in 2013 and is based in San Francisco, California.

InteSpring Logo

InteSpring is an engineering consultancy firm that specializes in the development of energy balancing solutions. The company's main offerings include the development of systems that balance force and gravity to enhance the performance of humans and devices, with a particular focus on integrated spring systems, wearable devices, and human interactive mechanisms. InteSpring primarily serves sectors such as the medical industry, defense, and logistics. It was founded in 2006 and is based in Delft, Netherlands.

Mobius Bionics Logo
Mobius Bionics

Mobius Bionics is a medical device company that operates in the healthcare sector, specifically focusing on advanced prosthetic technologies. The company's main product is a modular prosthetic arm, designed for different levels of amputation, which can be controlled by various input devices and features multiple pre-programmed grip patterns. The primary market for these products is the healthcare industry, particularly serving upper-limb amputees. It is based in Manchester, New Hampshire.

Marsi Bionics Logo
Marsi Bionics

Marsi Bionics develops exoskeletons that give mobility to injured and disabled people. It offers modular gait exoskeletons, ranging from single-joint active orthoses to full trunk, hip, knee, ankle, and foot active orthoses. The company was founded in 2013 and is based in Madrid, Spain.

Pedasys Logo

Pedasys is a company that focuses on the design and manufacture of power-assisted robots and rehabilitation systems, operating in the healthcare and technology sectors. The company's main products are robotic exoskeletons that assist individuals with mobility impairments or disabilities, enabling them to perform daily activities such as standing, sitting, and walking. The company primarily serves the healthcare industry, specifically targeting disabled and elderly individuals. It was founded in 2014 and is based in Tehran, Iran, Islamic Republic of.

Rejoint Logo

Rejoint is a start-up focused on new technology and surgical approaches in Total Knee Arthroplasty. Rejoint has developed a solution for knee replacement based on the integration of 3D Additive Manufacturing (AM), Artificial Intelligence (AI), and Internet of Things (IoT), which enables the design of personalized implants and surgical simulation based on unique patient anatomy.


CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.